Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder

NCT ID: NCT07337889

Last Updated: 2026-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

194 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2028-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to explore a novel conceptualization of Borderline Personality Disorder (BPD) as a "Relationship Use Disorder." The research proposes that BPD shares key features with behavioral addictions, specifically addiction to interpersonal relationships. The study builds upon previous findings suggesting that individuals with BPD experience intense emotional dysregulation, including negative self-perception, shame, and a compulsive need for external validation. This addiction to relationships, much like substance use disorders, is thought to contribute significantly to the difficulties faced by these individuals, including interpersonal conflicts, self-destructive behaviors, and emotional instability.

The study seeks to demonstrate that the relational difficulties central to BPD meet the diagnostic criteria for addiction as defined by the DSM-5. It will also explore how these relational struggles are mediated by dysfunctional self-perception and whether they are linked to behaviors such as compulsive sexual behaviors (CSBD) or suicidal tendencies. Additionally, the research will investigate the relationship between addiction to relationships and neurobiological factors, including endorphin levels, in individuals with BPD compared to those with bipolar disorder and healthy controls. The hypothesis is that individuals with BPD will exhibit higher levels of relationship addiction, with this addiction being tied to their perception of self-worth and emotional experiences in relationships.

This innovative approach aims to refine the understanding of BPD, reduce stigma, and improve treatment strategies by providing scientific evidence supporting the conceptualization of BPD as a "Relationship Use Disorder."

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Borderline Personality Disorder Borderline Personality Disorder (BPD) Bipolar Disorder (BD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with borderline personality

Patients with borderline personality disorder without bipolar disorder

Group Type EXPERIMENTAL

Relationship-use questionnaire

Intervention Type OTHER

Questionnaire adapted from the 'Substance Use Disorders' section of the DSM-5: Disorder related to the use of close relationships

Patients with bipolar disorder

patients with bipolar disorder without borderline personality disorder

Group Type EXPERIMENTAL

Relationship-use questionnaire

Intervention Type OTHER

Questionnaire adapted from the 'Substance Use Disorders' section of the DSM-5: Disorder related to the use of close relationships

Healthy controls

Healthy controls (i.e. without psychiatric disorders), from the general population

Group Type EXPERIMENTAL

Relationship-use questionnaire

Intervention Type OTHER

Questionnaire adapted from the 'Substance Use Disorders' section of the DSM-5: Disorder related to the use of close relationships

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Relationship-use questionnaire

Questionnaire adapted from the 'Substance Use Disorders' section of the DSM-5: Disorder related to the use of close relationships

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* General : aged 18-45
* Specific :
* Borderline personality disorder (BPD)assessed by SCID, without bipolar disorder
* Bipolar disorder (assessed by SCID), without BPD (evaluated by SCID)
* Healthy controls with no psychiatric disorders (screened by SCID).

Exclusion Criteria

* Psychotic disorders (evaluated by SCID)
* lack of informed consent
* Not affiliated with social security
* Under judicial or administrative confinement or involuntary hospitalization
* Protected by law (e.g., under guardianship)
* Pregnancy or breastfeeding
* Inability to understand, speak, or write in French
* Inability to understand the study's purpose or methodology
* Excluded from another study during the exclusion period
* Participants who have received over €6000 in annual indemnities
* For Bipolar Participants (without BPD) : Current moderate or severe depressive episode (BDI score \> 18) or Current hypomanic/manic episode (YMRS \< 12)
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL24_0194

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.